RxDoctor Payments Data

Hassaan Zia, MD

Gastroenterology · Milwaukee, WINPI 1669887519

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.8%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Olympus Corporation Of The Americas at 32.6% of the total. Reporting peaked in 2023 at $2,376 and has fallen 80.6% since, to $461 in 2025. Among gastroenterology clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,650in general payments, 2019–2025

Across 198 payments — averaging $43.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation Of The Americas$3K
  • Boston Scientific$2K
  • AbbVie$828
  • Cook Medical LLC$800
  • Johnson & Johnson$437
  • Apollo Endosurgery US Inc$320
  • plus $2K from 16 others

What the payments were for

  • Grants$8009%
  • Travel & lodging$3,80444%
  • Food & beverage$4,04647%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,650 in reported general payments places this provider in the 90th percentile of 285 gastroenterology providers in Wisconsin.

See all gastroenterology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$59,313
Medicare patients
279
Services billed
433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole71$666
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl24$422
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl28$391
Famotidine22$282
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg11$194

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Milwaukee

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →